Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ATIR101
ATIR101
Kiadis dumps phase 3 drug, halves head count in pivot to NK cells
Fierce Biotech
Wed, 11/13/19 - 09:57 am
Kiadis
clinical trials
ATIR101
solid tumors